There are many reports of how CBD isolates have helped a lot of people get relief from different symptoms, including pains, stress, inflammation, nausea, etc. But are you aware of the potential of this form of cannabidiol (CBD)? Probably NO! Many people tend to focus more on the full-spectrum CBD due to the entourage effects… Continue reading CBD Isolate: How it can Benefit You?
Category: CBD
What’s CBD Isolate and Why Does It Matter?
If you consider all that has been written about Cannabidiol (CBD), you would find that very little attention is paid to CBD isolates. Many are blown away by the benefits of full-spectrum CBD and the talks of the entourage effects that they often pay no mind to the isolates. But that in my opinion is… Continue reading What’s CBD Isolate and Why Does It Matter?
CBD giant Charlotte’s Web positions to enter THC market
Hemp-derived CBD giant Charlotte’s Web Holdings is positioning itself to enter THC and marijuana markets. The Boulder, Colorado, company says it has signed a five-year, $8 million purchase agreement option with a marijuana company started by its founders, Stanley Brothers USA Holdings Inc. The deal allows Charlotte’s Web to take over the marijuana business after… Continue reading CBD giant Charlotte’s Web positions to enter THC market
Minor cannabinoids are a ‘new frontier’ in wellness: Q&A with Jonathan Vaught, CEO of Front Range Biosciences
Minor cannabinoids have been gathering interest among growers and extractors over the past year, with research on CBG, CBN, CBC and THC-V showing unique health benefits for consumers. But are consumers even aware of these molecules and is there demand in the marketplace? And are there genetics available that can yield enough of these minor… Continue reading Minor cannabinoids are a ‘new frontier’ in wellness: Q&A with Jonathan Vaught, CEO of Front Range Biosciences
Genetic editing offers hemp and marijuana companies a way to improve plant strains
This story first appeared at Marijuana Business Daily. The development of new genetic-editing technology offers cannabis companies a cost-effective way to make specific changes to marijuana and hemp plants – such as more disease resistance – without creating a genetically modified organism. The technology, known as Crispr-Cas9, will allow the cannabis industry to build new,… Continue reading Genetic editing offers hemp and marijuana companies a way to improve plant strains
Study: Most high-CBD hemp plants are 90% marijuana, genetically
High-CBD plants inherit approximately 90% of their genes from marijuana, according to a new cannabis genomics study by the University of Minnesota and hemp breeding company Sunrise Genetics. The collaborators assembled a complete genome from a new cannabis variety and also examined several different cannabis varieties. They found that by breeding high-THC marijuana plants with… Continue reading Study: Most high-CBD hemp plants are 90% marijuana, genetically
Cannabinoids can improve skin, study says
This story first appeared at Marijuana Business Daily. The development and extensive marketing of cosmetics containing cannabinoids—primarily CBD—has occurred in the absence of solid scientific evidence of their efficacy. Can cannabinoids even be absorbed into skin and, if so, can they have beneficial health effects? A recently published study suggests they can. Researchers in Poland… Continue reading Cannabinoids can improve skin, study says
Lucky Strike’s parent company now selling CBD vapes
British American Tobacco is selling flavored CBD vapes in the United Kingdom as it eyes new products beyond tobacco and nicotine. But the parent company of Lucky Strike says it is not ready to enter the THC market yet. The company’s Chief Marketing Officer, Kingsley Wheaton, told CNBC this week that CBD is an “exciting… Continue reading Lucky Strike’s parent company now selling CBD vapes
Judge: CBD company did not mislead investors
U.S. District Court for the Eastern District of New York Crediting the CBD company’s forthrightness, a federal judge in New York federal judge has dismissed a lawsuit against Massachusetts-based Curaleaf from investors who argued the company misled them about legality of its CBD products. The investors sued when Curaleaf’s share price fell in 2019 after… Continue reading Judge: CBD company did not mislead investors
NFL requesting research on CBD for pain management
The National Football League and its players’ union have requested industry research on CBD and other cannabinoids for pain management. The NFL says it is looking for information about “alternatives to opioids in routine pain management.” The request mentions CBD but is open to research on other cannabinoids. The request issued Wednesday also mentions research… Continue reading NFL requesting research on CBD for pain management
Autoflower hemp will rule emerging CBD global powerhouse regions of Southeast Asia and Latin America
LONGMONT, COLO, February 17, 2021 — Hemp seed breeder Trilogene Seeds releases three new autoflower hemp varietals for 2021 seed sales, a bid to meet the needs of hemp growers in regions like Thailand and Latin America predicted to dominate the future of global CBD hemp production. After 80 years of prohibition, Thailand is the… Continue reading Autoflower hemp will rule emerging CBD global powerhouse regions of Southeast Asia and Latin America
SōRSE Technology debuts water-soluble 7.5% CBD emulsion for personal care products at live webinar on February 25th
SōRSE Technology, the leading water-soluble emulsion technology designed for infusing functional ingredients into consumer goods, announces the addition of 7.5% CBD liquid emulsion for personal care products to their product suite. SōRSE is designed for product developers to make oil-based functional ingredients water-soluble and more efficacious, while also providing the consumer with a consistent, safe… Continue reading SōRSE Technology debuts water-soluble 7.5% CBD emulsion for personal care products at live webinar on February 25th
Opinion: Hope is not a strategy, so stop tolling
(Editor’s note: This story is part of a recurring series of commentaries from professionals connected to the hemp industry. Julie Lerner is CEO of PanXchange, a commodity trading platform and benchmark price provider.) Basing the multibillion-dollar, pie-in-the-sky forecasts for the U.S. addressable market for CBD on retail shelf prices disturbs me. It’s as illogical as… Continue reading Opinion: Hope is not a strategy, so stop tolling
CBD maker GW Pharma agrees to $7.2 billion acquisition by Ireland’s Jazz Pharmaceuticals
(A version of this story originally appeared at Marijuana Business Daily and will be updated.) An Irish pharmaceutical firm, Jazz Pharmaceuticals, has agreed to purchase United Kingdom-based GW Pharmaceuticals, one of the largest medical cannabinoid companies in the world, for $7.2 billion, the drug companies said Wednesday. The proposed cash-and-stock deal would be the largest… Continue reading CBD maker GW Pharma agrees to $7.2 billion acquisition by Ireland’s Jazz Pharmaceuticals
Want to promote hemp’s health benefits? Here’s how to do it without getting in trouble
Hemp businesses walk a fine line when describing the health benefits of their products: Make a claim without evidence or wording that misleads consumers, and soon the legal fees will pile up. The U.S. Food and Drug Administration has guidelines for acceptable claims to make on labels for dietary supplements – the closest fit for… Continue reading Want to promote hemp’s health benefits? Here’s how to do it without getting in trouble
L’Oreal, Neutrogena alumna tapped to lead California CBD maker Papa & Barkley
A cosmetics executive has been tapped to take over California CBD manufacturer Papa & Barkley. Evelyn Wang replaces Adam Grossman as CEO. Grossman will lead the company’s board of directors. Wang comes from Milani Cosmetics. She was formerly an assistant vice president for L’Oreal Paris, and before that was Product Director for Neutrogena Cosmetics, part… Continue reading L’Oreal, Neutrogena alumna tapped to lead California CBD maker Papa & Barkley
FDA withdraws pending CBD enforcement proposal
U.S. drug regulators have withdrawn their proposal to regulate over-the-counter CBD, handing the industry another setback after years of delay from the Food and Drug Administration. The proposal in question appears to be on pause because of the changing administration. The delay was widely anticipated but still frustrating for CBD operators awaiting the rules. The… Continue reading FDA withdraws pending CBD enforcement proposal
GW Pharma expects fiscal 2020 sales to reach $526 million
This story first appeared at Marijuana Business Daily International. United Kingdom-based GW Pharmaceuticals expects to report annual sales of approximately $526 million for the year ended Dec. 31, 2020, it said in a preview of its fourth quarter and full-year results. Fourth-quarter net sales will be approximately $148 million, based on preliminary unaudited financial information,… Continue reading GW Pharma expects fiscal 2020 sales to reach $526 million
Molson Coors, HEXO launch CBD drinks in Colorado
Molson Coors Beverage Co. says it has launched CBD drinks in Colorado through TRUSS CBD USA, its joint venture with HEXO Corp. The beverage line will be available in three flavors – Grapefruit Tarragon, Strawberry Hibiscus and Blueberry Lavender under the name, “Verywell,” Molson Coors and HEXO said Wednesday. The companies first partnered in 2018… Continue reading Molson Coors, HEXO launch CBD drinks in Colorado
FDA says it seeks ‘real world data’ to fill in CBD research gaps in ‘end of administration’ update
Federal food and drug officials said Friday that they plan to fill in current CBD research gaps with “real world data” — but industry advocates are frustrated that regulators haven’t done enough to clear up the rules, which has caused supply-chain bottlenecks while leaving consumers to navigate an increasing field of unregulated products. An update… Continue reading FDA says it seeks ‘real world data’ to fill in CBD research gaps in ‘end of administration’ update